brivaracetam
NDC 73473-908, brivaracetam, tablet, film coated, from Solaris�Pharma�Corporation.
- Product NDC
- 73473-908
- Status
- Listed
- Labeler
- Solaris�Pharma�Corporation
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA214748
- DEA schedule
- CV
curl https://api.healthcare.dev/v1/drugs/ndc/73473-908 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BRIVARACETAM100 mg/1
Pharmacologic classes
Epoxide Hydrolase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 73473-908-60 | 73473090860 | 60 TABLET, FILM COATED in 1 BOTTLE (73473-908-60) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/49f726ec-e51b-7516-e063-6294a90ae684NADAC price for package 73473090860
GET /v1/drugs/nadac/73473090860
Use it
Look up 73473-908 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/73473-908 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 73473-908. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.